Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

NPPA Fixes Retail Rates for 36 Key Drugs Like Atorvastatin, Dapagliflozin, Gemcitabine

NPPA Committee Caps Price of Akums' Cetirizine Eye Drops at Rs 14.42 per ml

Susmita Roy3 Jan 2026 4:49 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Cetirizine Hydrochloride IP eq. to Cetirizine 0.24 % w/v...

WHO Alert Spurs Indias Probe Into Deadly Cough Syrup, Licence Cancelled, 700 Plus Units Audited, Parliament Informed

Govt Proposes Stricter Controls on Syrups, Seeks Removal From Schedule K

Susmita Roy2 Jan 2026 9:00 PM IST

New Delhi: With an aim to reinforce drug safety, improve manufacturing oversight, and protect vulnerable patients, especially children, through a...

Haryana Flags Over 30 Drug Overcharging Cases, Seeks NPPA Action

Despite Price Caps, Pharma Firms Overcharged Patients by Rs 10,000+ Cr: NPPA

Susmita Roy2 Jan 2026 8:52 PM IST

New Delhi: Despite price ceilings imposed on essential medicines to protect patients, pharmaceutical companies across India have allegedly overcharged...

Alkem Secures CDSCO Panel Approval for Synthetic Semaglutide in Obesity Management

Susmita Roy2 Jan 2026 5:48 PM IST

New Delhi: Drug major Alkem Laboratories Limited has received a key regulatory clearance from the Subject Expert Committee (SEC) functioning under the...

USFDA Grants Orphan Drug Status to Shilpa-mAbTree Biologic for Rare Blood Cancers

Delhi HC Bars Shilpa Medicare From Making, Selling Ruxolitinib Drugs in Patent Row

Susmita Roy1 Jan 2026 6:14 PM IST

New Delhi: Shilpa Medicare has received an ex-parte ad-interim injunction order from the Delhi High Court, restraining the company and its...

Pfizer Slapped With Rs 8.79 Cr GST Demand Over Alleged ITC Irregularities, Plans Appeal

Susmita Roy1 Jan 2026 5:19 PM IST

New Delhi: Pfizer has received a tax demand order amounting to Rs 8.79 crore, including penalty, from the Office of the Additional Commissioner of GST...

Sun Pharma Names Sana Shaikh as Head of Marketing

Sun Pharma Gets CDSCO Panel Nod to Market Semaglutide Injection in Weight Loss Indication

Susmita Roy1 Jan 2026 5:06 PM IST

New Delhi: Drug major Sun Pharmaceutical Industries Limited has received a key regulatory clearance from the Subject Expert Committee (SEC)...

Unrestricted Antibiotic Sales via E-Pharmacies: AIOCD Flags AMR Risk, Seeks PM Modi's Intervention

Susmita Roy31 Dec 2025 11:42 AM IST

New Delhi: In a strong appeal flagging an escalating public health emergency, the All India Organisation of Chemists and Druggists (AIOCD) has urged...

GeneSys Biologics Gets SEC Nod to Market Insulin Glargine, Phase IV Study Mandated

Susmita Roy31 Dec 2025 11:25 AM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted permission to GeneSys...

Abuse of the Process of Law: Delhi HC Upholds Dismissal of Complaint Against Hospital, Doctor Accused of Medical Negligence

Triple Identity Case: Delhi HC Bans Infringing Sun Pharma's PEPFIX-DSR, MINOZIL Marks

Susmita Roy30 Dec 2025 4:20 PM IST

New Delhi: The Delhi High Court has granted a summary judgment in favor of Sun Pharmaceutical Industries, permanently restraining Oziel...

Cipla Gets CDSCO Panel Nod to Begin Phase III Study of Semaglutide Injection

Susmita Roy30 Dec 2025 2:27 PM IST

New Delhi: Drug major Cipla Limited has received clearance from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard...

Stapler Pin Found in Tablet: Consumer Court Orders Two Pharma Firms to Pay Rs 1 Lakh

Susmita Roy29 Dec 2025 11:21 PM IST

New Delhi: In an alarming incident highlighting lapses in pharmaceutical quality control, the District Consumer Disputes Redressal Commission has...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok